Endpoints for Clinical Trials Testing Treatment of Acute Graft-versus-Host Disease: A Joint Statement
Open Access
- 31 July 2009
- journal article
- review article
- Published by Elsevier BV in Transplantation and Cellular Therapy
- Vol. 15 (7), 777-784
- https://doi.org/10.1016/j.bbmt.2009.03.012
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomesBlood, 2009
- Study design and endpoints in graft-versus-host diseaseBest Practice & Research Clinical Haematology, 2008
- Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host diseaseBlood, 2008
- Titrating graft-versus-host disease: is it worth a try?Bone Marrow Transplantation, 2006
- Structure of the DPS-Like Protein from Sulfolobus solfataricus Reveals a Bacterioferritin-Like Dimetal Binding Site within a DPS-Like Dodecameric Assembly,Biochemistry, 2006
- The Clinical Spectrum of Acute Graft-Versus-Host DiseaseSeminars in Hematology, 2006
- Pitfalls in the Design of Clinical Trials for Prevention or Treatment of Acute Graft-versus-Host DiseaseTransplantation and Cellular Therapy, 2006
- Effect of up-front daclizumab when combined with steroids for the treatment of acute graft-versus-host disease: results of a randomized trialBlood, 2004
- Single versus Double Autologous Stem-Cell Transplantation for Multiple MyelomaThe New England Journal of Medicine, 2003
- Electrospray ionization of large multiply charged species proceeds via Dole’s charged residue mechanismAnalytica Chimica Acta, 2000